Ainos, Inc.
NASDAQ: AIMD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Chun-Hsien Tsai
- Employees
- 44
- Headquarters
- San Diego, United States
- IPO year
- 2021
- Market cap
- $8.1M
- Website
- https://ainos.com
Loading AIMD…
Loading profile data…Frequently asked questions about AIMD
What does Ainos, Inc. (AIMD) do?
Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both p...
Where does AIMD trade?
Ainos, Inc. (AIMD) trades on the NASDAQ Capital Market.
What sector is AIMD in?
Ainos, Inc. (AIMD) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Ainos, Inc.?
Chun-Hsien Tsai is the chief executive officer of Ainos, Inc. (AIMD).
Where is Ainos, Inc. headquartered?
Ainos, Inc. is headquartered in United States.
Does AIMD pay a dividend?
Ainos, Inc. (AIMD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AIMD go public?
Ainos, Inc. (AIMD) completed its initial public offering in 2021.